1
|
Melero R, Quiroz-Rodríguez ME, Lara-Hernández F, Redón J, Sáez G, Briongos-Figuero LS, Abadía-Otero J, Martín-Escudero JC, Chaves FJ, Ayala G, García-García AB. Corrigendum to "Genetic interaction in the association between oxidative stress and diabetes in the Spanish population" [Free Radic. Biol. Med. 205 (2023) 62-68]. Free Radic Biol Med 2023; 207:181-182. [PMID: 37487450 DOI: 10.1016/j.freeradbiomed.2023.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/26/2023]
Affiliation(s)
- Rebeca Melero
- Genomics and Diabetes Unit. INCLIVA Biomedical Research Institute, 46010, Valencia, Spain
| | | | | | - Josep Redón
- Cardiometabolic Renal Risk Research Group, INCLIVA Biomedical Research Institute, University of Valencia, 46010, Valencia, Spain; CIBEROBN, ISCIII, 28029, Madrid, Spain
| | - Guillermo Sáez
- Department of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology. University of Valencia, 46010, Valencia, Spain; Service of Clinical Analysis, University Hospital Dr. Peset-FISABIO, Spain
| | | | - Jessica Abadía-Otero
- Department of Internal Medicine, Rio Hortega University Hospital, 47012, Valladolid, Spain
| | - Juan Carlos Martín-Escudero
- Department of Internal Medicine, Rio Hortega University Hospital, 47012, Valladolid, Spain; Department of Medicine, Faculty of Medicine, University of Valladolid, 47002, Valladolid, Spain
| | - F Javier Chaves
- Genomics and Diabetes Unit. INCLIVA Biomedical Research Institute, 46010, Valencia, Spain; CIBERDEM, ISCIII, 28029, Madrid, Spain.
| | - Guillermo Ayala
- Department of Statistics and Operation Research, University of Valencia, 46100, Burjassot, Valencia, Spain
| | - Ana-Bárbara García-García
- Genomics and Diabetes Unit. INCLIVA Biomedical Research Institute, 46010, Valencia, Spain; CIBERDEM, ISCIII, 28029, Madrid, Spain
| |
Collapse
|
2
|
Melero R, Quiroz-Rodríguez ME, Lara-Hernández F, Redón J, Sáez G, Briongos-Figuero LS, Abadía-Otero J, Martín-Escudero JC, Chaves FJ, Ayala G, García-García AB. Genetic interaction in the association between oxidative stress and diabetes in the Spanish population. Free Radic Biol Med 2023; 205:62-68. [PMID: 37268047 DOI: 10.1016/j.freeradbiomed.2023.05.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Revised: 05/24/2023] [Accepted: 05/30/2023] [Indexed: 06/04/2023]
Abstract
Oxidative stress (OS) is a relevant intermediate mechanism involved in Type 2 Diabetes Mellitus (T2D) development. To date, the interaction between OS parameters and variations in genes related to T2D has not been analyzed. AIMS To study the genetic interaction of genes potentially related to OS levels (redox homeostasis, renin-angiotensin-aldosterone system, endoplasmic stress response, dyslipidemia, obesity and metal transport) and OS and T2D risk in a general population from Spain (the Hortega Study) in relation to the risk of suffering from T2D. MATERIALS AND METHODS One thousand five hundred and two adults from the University Hospital Rio Hortega area were studied and 900 single nucleotide polymorphisms (SNPs) from 272 candidate genes were analyzed. RESULTS There were no differences in OS levels between cases and controls. Some polymorphisms were associated with T2D and with OS levels. Significant interactions were observed between OS levels and two polymorphisms in relation to T2D presence: rs196904 (ERN1 gene) and rs2410718 (COX7C gene); and between OS levels and haplotypes of the genes: SP2, HFF1A, ILI8R1, EIF2AK2, TXNRD2, PPARA, NDUFS2 and ERN1. CONCLUSIONS Our results indicate that genetic variations of the studied genes are associated with OS levels and that their interaction with OS parameters may contribute to the risk of developing T2D in the Spanish general population. These data support the importance of analyzing the influence of OS levels and their interaction with genetic variations in order to establish their real impact in T2D risk. Further studies are required to identify the real relevance of interactions between genetic variations and OS levels and the mechanisms involved in them.
Collapse
Affiliation(s)
- Rebeca Melero
- Genomics and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain
| | | | | | - Josep Redón
- Cardiometabolic Renal Risk Research Group, INCLIVA Biomedical Research Institute, University of Valencia, 46010, Valencia, Spain; CIBEROBN, ISCIII, 28029, Madrid, Spain
| | - Guillermo Sáez
- Department of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology, University of Valencia, 46010, Valencia, Spain; Service of Clinical Analysis, University Hospital Dr. Peset-FISABIO, Spain
| | | | - Jessica Abadía-Otero
- Department of Internal Medicine, Rio Hortega University Hospital, 47012, Valladolid, Spain
| | - Juan Carlos Martín-Escudero
- Department of Internal Medicine, Rio Hortega University Hospital, 47012, Valladolid, Spain; Department of Medicine, Faculty of Medicine, University of Valladolid, 47002, Valladolid, Spain
| | - F Javier Chaves
- Genomics and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain; CIBERDEM, ISCIII, 28029, Madrid, Spain.
| | - Guillermo Ayala
- Department of Statistics and Operation Research, University of Valencia, 46100, Burjassot, Valencia, Spain
| | - Ana-Bárbara García-García
- Genomics and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain; CIBERDEM, ISCIII, 28029, Madrid, Spain
| |
Collapse
|
3
|
Usategui-Martín R, Pérez-Castrillón JL, Mansego ML, Lara-Hernández F, Manzano I, Briongos L, Abadía-Otero J, Martín-Vallejo J, García-García AB, Martín-Escudero JC, Chaves FJ. Association between genetic variants in oxidative stress-related genes and osteoporotic bone fracture. The Hortega follow-up study. Gene 2022; 809:146036. [PMID: 34688818 DOI: 10.1016/j.gene.2021.146036] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 10/15/2021] [Accepted: 10/19/2021] [Indexed: 11/20/2022]
Abstract
The most widely accepted etiopathogenesis hypothesis of the origin of osteoporosis and its complications is that they are a consequence of bone aging and other environmental factors, together with a genetic predisposition. Evidence suggests that oxidative stress is crucial in bone pathologies associated with aging. The aim of this study was to determine whether genetic variants in oxidative stress-related genes modified the risk of osteoporotic fracture. We analysed 221 patients and 354 controls from the HORTEGA sample after 12-14 years of follow up. We studied the genotypic and allelic distribution of 53 SNPs in 24 genes involved in oxidative stress. The results showed that being a carrier of the variant allele of the SNP rs4077561 within TXNRD1 was the principal genetic risk factor associated with osteoporotic fracture and that variant allele of the rs1805754 M6PR, rs4964779 TXNRD1, rs406113 GPX6, rs2281082 TXN2 and rs974334 GPX6 polymorphisms are important genetic risk factors for fracture. This study provides information on the genetic factors associated with oxidative stress which are involved in the risk of osteoporotic fracture and reinforces the hypothesis that genetic factors are crucial in the etiopathogenesis of osteoporosis and its complications.
Collapse
Affiliation(s)
- Ricardo Usategui-Martín
- IOBA, University of Valladolid, Valladolid. Spain; Cooperative Health Network for Research (RETICS), Oftared, National Institute of Health Carlos III, ISCIII, Madrid. Spain.
| | - José Luis Pérez-Castrillón
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine. Faculty of Medicine. University of Valladolid, Valladolid, Spain.
| | - María L Mansego
- Genomic and Genetic Diagnosis Unit, INCLIVA Biomedical Research Institute, Valencia, Spain; Department of Bioinformatics. Making Genetics S.L. Pamplona. Spain
| | | | - Iris Manzano
- Genomic and Genetic Diagnosis Unit, INCLIVA Biomedical Research Institute, Valencia, Spain
| | - Laisa Briongos
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine. Faculty of Medicine. University of Valladolid, Valladolid, Spain
| | - Jesica Abadía-Otero
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain
| | - Javier Martín-Vallejo
- Department of Statistics. University of Salamanca. Salamanca Biomedical Research Institute (IBSAL), Salamanca. Spain
| | - Ana B García-García
- Genomic and Genetic Diagnosis Unit, INCLIVA Biomedical Research Institute, Valencia, Spain; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid. Spain
| | - Juan Carlos Martín-Escudero
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine. Faculty of Medicine. University of Valladolid, Valladolid, Spain
| | - Felipe J Chaves
- Genomic and Genetic Diagnosis Unit, INCLIVA Biomedical Research Institute, Valencia, Spain; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid. Spain
| |
Collapse
|
4
|
Usategui-Martín R, Pérez-Castrillón JL, Briongos-Figuero L, Abadía-Otero J, Lara-Hernandez F, García-Sorribes S, Martín-Vallejo J, García-García AB, Chaves FJ, Martín-Escudero JC. Genetic variants in obesity-related genes and the risk of osteoporotic fracture. The Hortega Follow-up Study. FRONT BIOSCI-LANDMRK 2022; 27:32. [DOI: 10.31083/j.fbl2701032] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 12/28/2021] [Accepted: 12/28/2021] [Indexed: 11/06/2022]
|
5
|
Briongos-Figuero LS, Cobos-Siles M, Gabella-Martín M, Abadía-Otero J, Lobo-Valentin R, Aguado-De-La-Fuente A, Vargas-Ruiz B, Martín-Escudero JC. Evaluation and characterization of multimorbidity profiles, resource consumption and healthcare needs in extremely elderly people. Int J Qual Health Care 2021; 32:266-270. [PMID: 32232326 DOI: 10.1093/intqhc/mzaa022] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Revised: 12/09/2019] [Accepted: 02/26/2020] [Indexed: 12/24/2022] Open
Abstract
OBJECTIVES Spanish population lifespan is one of the longest in the world. Moreover, it is known that elderly people have less chronic illnesses associated with aging. Our aims were to determine how Clinical Risk Group (CRG) predicts future use of healthcare resources in extremely elderly people without diabetes (T2DM) and to explore CRG correlation with health conditions. DESIGN Prospective cross-sectional study. SETTING Rio Hortega University Hospital. PARTICIPANTS Hospitalized patients >80 years old without T2DM, during 2017. MAIN OUTCOME MEASURES Mental status was evaluated using Pfeiffer test (SPMQS), Basic Activities of Daily Living (BADLs) and Instrumental Activities of Daily Living (IADLs) were estimated using the Older Americans Resources and Services questionnaire. Comorbidity was evaluated using Charlson index (CI) and health-related quality of life (HRQoL) with EuroQoL (EQ5D3L). CRG classification system was obtained from electronic clinical records. Data were analyzed using SPSS v.15.0. RESULTS In total, 305 patients were identified (59% women), mean age 88 ± 5 and 38% were aged >90. Estimated HRQoL was 0.43 ± 0.33 for EQ5D3L-index-value. Mean dependence level was 6.2 ± 5 for BADLs and 9.2 ± 5 for IADLs. In total, 31.6% of patients had severe cognitive impairment with a mean score of 5.4 ± 3.6 in SPMQS. In total, 30.2% of patients were categorized as G3, and presented high comorbidity more frequently than the rest. Corrected CI mean score was 6.2 ± 1.7. Significant relationship was founded in survival time, number of admissions and CI score. CONCLUSIONS Using predictive risk models like CRG is supposed to assess the complexity of morbidity but in our extremely elderly population partially fail in stratify and predict health resource consumption.
Collapse
Affiliation(s)
| | - Marta Cobos-Siles
- Internal Medicine Service, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | - Miriam Gabella-Martín
- Internal Medicine Service, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | - Jesica Abadía-Otero
- Internal Medicine Service, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | - Rosa Lobo-Valentin
- Clinical Chemistry Laboratory, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | - Ana Aguado-De-La-Fuente
- Nursing Care Department, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | - Beatriz Vargas-Ruiz
- Nursing Care Department, Rio Hortega University Hospital, C/Dulzaina 2, 47012 Valladolid, Spain
| | | |
Collapse
|
6
|
Usategui-Martín R, Lendinez-Tortajada V, Pérez-Castrillón JL, Briongos-Figuero L, Abadía-Otero J, Martín-Vallejo J, Lara-Hernandez F, Chaves FJ, García-Garcia AB, Martín-Escudero JC. Polymorphisms in genes involved in inflammation, the NF-kB pathway and the renin-angiotensin-aldosterone system are associated with the risk of osteoporotic fracture. The Hortega Follow-up Study. Bone 2020; 138:115477. [PMID: 32535289 DOI: 10.1016/j.bone.2020.115477] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Revised: 06/02/2020] [Accepted: 06/09/2020] [Indexed: 02/07/2023]
Abstract
Osteoporosis is the most common bone disorder worldwide and is associated with a reduced quality of life with important clinical and economic consequences. The most widely accepted etiopathogenic hypothesis on the origin of osteoporosis and its complications is that they are a consequence of the synergic action of environmental and genetic factors. Bone is constantly being remodelled through anabolic and catabolic pathways in which inflammation, the NF-kB pathway and the renin-angiotensin-aldosterone system (RAAS) are crucial. The aim of our study was to determine whether polymorphisms in genes implicated in inflammation, the NF-kB pathway and RAAS modified the risk of osteoporotic fracture. We analysed 221 patients with osteoporotic fracture and 354 controls without fracture from the HORTEGA sample after 12-14 years of follow up. In addition, we studied the genotypic distribution of 230 single nucleotide polymorphisms (SNPs) in genes involved in inflammation, NF-kB pathway and RAAS. Our results showed that be carrier of the C allele of the rs2228145 IL6R polymorphism was the principal genetic risk factor associated with osteoporotic fracture. The results also showed that variant genotypes of the rs4762 AGT, rs4073 IL8, rs2070699 END1 and rs4291 ACE polymorphisms were important genetic risk factors for fracture. The study provides information about the genetic factors associated with inflammation, the NF-kB pathway and RAAS, which are involved in the risk of osteoporotic fracture and reinforces the hypothesis that genetic factors are crucial in the etiopathogenesis of osteoporosis and its complications.
Collapse
Affiliation(s)
| | - Verónica Lendinez-Tortajada
- Genomic and Genetic Diagnosis Unit, Instituto de Investigación Sanitaria Clínico de Valencia, INCLIVA, Valencia, Spain.
| | - José Luis Pérez-Castrillón
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine, Faculty of Medicine, University of Valladolid, Valladolid, Spain.
| | | | - Jesica Abadía-Otero
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine, Faculty of Medicine, University of Valladolid, Valladolid, Spain
| | - Javier Martín-Vallejo
- Department of Statistics, University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), Salamanca, Spain.
| | - Francisco Lara-Hernandez
- Genomic and Genetic Diagnosis Unit, Instituto de Investigación Sanitaria Clínico de Valencia, INCLIVA, Valencia, Spain
| | - Felipe J Chaves
- Genomic and Genetic Diagnosis Unit, Instituto de Investigación Sanitaria Clínico de Valencia, INCLIVA, Valencia, Spain; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain.
| | - Ana B García-Garcia
- Genomic and Genetic Diagnosis Unit, Instituto de Investigación Sanitaria Clínico de Valencia, INCLIVA, Valencia, Spain; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain.
| | - Juan Carlos Martín-Escudero
- Department of Internal Medicine, Rio Hortega Universitary Hospital, Valladolid, Spain; Department of Medicine, Faculty of Medicine, University of Valladolid, Valladolid, Spain
| |
Collapse
|
7
|
Martínez-Barquero V, Marco GD, Martínez-Hervas S, Adam-Felici V, Pérez-Soriano C, Gonzalez-Albert V, Rojo G, Ascaso JF, Real JT, Garcia-Garcia AB, Martín-Escudero JC, Cortes R, Chaves FJ. Are IL18RAP gene polymorphisms associated with body mass regulation? A cross-sectional study. BMJ Open 2017; 7:e017875. [PMID: 29146643 PMCID: PMC5695454 DOI: 10.1136/bmjopen-2017-017875] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
OBJECTIVES To investigate the association between IL18RAP and body mass index (BMI) and obesity and to verify the effect of a polymorphism in the microRNA136 (MIR136) IL18RAP binding region. DESIGN We analysed samples from two Spanish cross-sectional studies, VALCAR (Spanish Mediterranean coast) and Hortega (Spanish centre). These studies aimed at analysing cardiovascular risk and development of cardiovascular disease in the general population. Both populations correspond to regions with different characteristics. SETTING Five IL18RAP single nucleotide polymorphisms were selected using the SYSNPs web tool and analysed by oligonucleotide ligation assay (SNPlex). For the MIR136 functional study, cells were transfected with plasmids containing different rs7559479 polymorphism alleles and analysed by luciferase reporter assays. PARTICIPANTS 1970 individuals (Caucasian, both genders): VALCAR (468) and Hortega (1502). RESULTS rs2293225, rs2272127 and rs7559479 showed the following associations: rs7559479 G allele correlated with a higher obesity risk (P=0.01; OR=1.82; 95% CI 1.15 to 2.87 for the VALCAR group; P=0.033; OR=1.35; 95% CI 1.03 to 1.79 for the Hortega population) and higher body mass index (BMI) values (P=0.0045; P=0.1 for VALCAR and Hortega, respectively); a significant association with obesity (P=0.0024, OR=1.44, 95% CI 1.14 to 1.82) and increased BMI values (P=0.008) was found when considering both populations together. rs2293225 T allele was associated with lower obesity risk (P=0.036; OR=0.60; 95% CI 0.35 to 0.96) and lower BMI values (P=0.0038; OR=1.41) while the rs2272127 G allele was associated with lower obesity risk (P=0.028; OR=0.66; 95% CI 0.44 to 0.97) only in the VALCAR population. A reporter assay showed that the presence of the A allele in rs7559479 was associated with increased MIR136 binding to IL18RAP. CONCLUSIONS Our results suggest that polymorphisms in IL18RAP influence susceptibility to obesity. We demonstrated that the A allele in rs7559479 increases MIR136 binding, which regulates IL-18 system activity.
Collapse
Affiliation(s)
- Vanesa Martínez-Barquero
- Department of Medicine, University of Valencia, Valencia, Spain
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Griselda de Marco
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Sergio Martínez-Hervas
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
- Department of Endocrinology and Nutrition Service, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - Victoria Adam-Felici
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Cristina Pérez-Soriano
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Verónica Gonzalez-Albert
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Gemma Rojo
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
- Department of Endocrinology and Nutrition Service, Hospital Regional Universitario, Instituto de Biomedicina de Málaga (IBIMA), Malaga, Spain
| | - Juan Francisco Ascaso
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
- Department of Endocrinology and Nutrition Service, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - José Tomás Real
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
- Department of Endocrinology and Nutrition Service, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - Ana Barbara Garcia-Garcia
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
| | | | - Raquel Cortes
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Felipe Javier Chaves
- Department of Genomic and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain
| |
Collapse
|
8
|
Martínez-Barquero V, de Marco G, Martínez-Hervas S, Rentero P, Galan-Chilet I, Blesa S, Morchon D, Morcillo S, Rojo G, Ascaso JF, Real JT, Martín-Escudero JC, Chaves FJ. Polymorphisms in endothelin system genes, arsenic levels and obesity risk. PLoS One 2015; 10:e0118471. [PMID: 25799405 PMCID: PMC4370725 DOI: 10.1371/journal.pone.0118471] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2014] [Accepted: 01/18/2015] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND/OBJECTIVES Obesity has been linked to morbidity and mortality through increased risk for many chronic diseases. Endothelin (EDN) system has been related to endothelial function but it can be involved in lipid metabolism regulation: Receptor type A (EDNRA) activates lipolysis in adipocytes, the two endothelin receptors mediate arsenic-stimulated adipocyte dysfunction, and endothelin system can regulate adiposity by modulating adiponectin activity in different situations and, therefore, influence obesity development. The aim of the present study was to analyze if single nucleotide polymorphisms (SNPs) in the EDN system could be associated with human obesity. SUBJECTS/METHODS We analyzed two samples of general-population-based studies from two different regions of Spain: the VALCAR Study, 468 subjects from the area of Valencia, and the Hortega Study, 1502 subjects from the area of Valladolid. Eighteen SNPs throughout five genes were analyzed using SNPlex. RESULTS We found associations for two polymorphisms of the EDNRB gene which codifies for EDN receptor type B. Genotypes AG and AA of the rs5351 were associated with a lower risk for obesity in the VALCAR sample (p=0.048, OR=0.63) and in the Hortega sample (p=0.001, OR=0.62). Moreover, in the rs3759475 polymorphism, genotypes CT and TT were also associated with lower risk for obesity in the Hortega sample (p=0.0037, OR=0.66) and in the VALCAR sample we found the same tendency (p=0.12, OR=0.70). Furthermore, upon studying the pooled population, we found a stronger association with obesity (p=0.0001, OR=0.61 and p=0.0008, OR=0.66 for rs5351 and rs3759475, respectively). Regarding plasma arsenic levels, we have found a positive association for the two SNPs studied with obesity risk in individuals with higher arsenic levels in plasma: rs5351 (p=0.0054, OR=0.51) and rs3759475 (p=0.009, OR=0.53). CONCLUSIONS Our results support the hypothesis that polymorphisms of the EDNRB gene may influence the susceptibility to obesity and can interact with plasma arsenic levels.
Collapse
Affiliation(s)
- Vanesa Martínez-Barquero
- Department of Medicine, University of Valencia, Valencia, Spain
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Griselda de Marco
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Sergio Martínez-Hervas
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- Service of Endocrinology and Nutrition, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - Pilar Rentero
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Inmaculada Galan-Chilet
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - Sebastian Blesa
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
| | - David Morchon
- Internal Medicine, Rio Hortega Hospital, University of Valladolid, Valladolid, Spain
| | - Sonsoles Morcillo
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- Service of Endocrinology and Nutrition, Hospital Regional Universitario, Málaga, Spain, Instituto de Biomedicina de Málaga (IBIMA), Málaga, Spain
| | - Gemma Rojo
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- Service of Endocrinology and Nutrition, Hospital Regional Universitario, Málaga, Spain, Instituto de Biomedicina de Málaga (IBIMA), Málaga, Spain
| | - Juan Francisco Ascaso
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- Service of Endocrinology and Nutrition, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - José Tomás Real
- Department of Medicine, University of Valencia, Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- Service of Endocrinology and Nutrition, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | | | - Felipe Javier Chaves
- Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation (INCLIVA), Valencia, Spain
- CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain
- * E-mail:
| |
Collapse
|
9
|
Llopis-González A, Rubio-López N, Pineda-Alonso M, Martín-Escudero JC, Chaves FJ, Redondo M, Morales-Suarez-Varela M. Hypertension and the fat-soluble vitamins A, D and E. Int J Environ Res Public Health 2015; 12:2793-809. [PMID: 25749317 PMCID: PMC4377933 DOI: 10.3390/ijerph120302793] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Revised: 02/24/2015] [Accepted: 02/25/2015] [Indexed: 12/27/2022]
Abstract
Hypertension affects populations globally and is thus a public health and socio-economic problem. Macronutrient and micronutrient deficiencies are common in the general population, and may be even more prevalent in hypertensive patients. This study aimed to determine a possible association between hypertension and intake of fat-soluble vitamins A, D and E. Participants were from the cross-sectional Hortega nutrition study conducted with a random sample of 1514 people (50.3% women, 49.7% men) and two groups: nonhypertensive controls ≥40 years old (n = 429; 28.3%); unknown untreated hypertension cases ≥40 years old (n = 246; 16.2%). Biochemical and anthropometric measurements were taken. Data on dietary intakes, education, socio-economic status, place of residence, health habits, comorbidities, alcohol consumption and smoking were collected and assessed. A descriptive data study was done and compared by ANOVA and Chi-Square. No p value higher than 0.05 was considered significant. The results showed that vitamin A intake was higher in the hypertensive subpopulation (1732.77 ± 962.27 µg vs. 1655.89 ± 902.81 µg), and vitamin D and E intakes were lower (8.13 ± 9.71 µg vs. 8.25 ± 9.52 µg and 18.79 ± 7.84 mg vs. 18.60 ± 8.20 mg, respectively). No statistically significant differences were found in any adjusted model. This study did not significantly associate intake of vitamins A, D and E with hypertension in people aged over 40. Future studies on this topic and a larger sample are necessary.
Collapse
Affiliation(s)
- Agustin Llopis-González
- Unit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46100 Valencia, Spain.
- CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
- Center for Advanced Research in Public Health (CSISP-FISABIO), 46010 Valencia, Spain.
| | - Nuria Rubio-López
- Unit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46100 Valencia, Spain.
- CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
- Center for Advanced Research in Public Health (CSISP-FISABIO), 46010 Valencia, Spain.
| | - Monica Pineda-Alonso
- Internal Medicine Department, Rio Hortega University Hospital, 47012 Valladolid, Spain.
| | | | - Felipe Javier Chaves
- Genotyping and Genetic Diagnosis Unit Hospital Clinic Research Foundation and INCLIVA, University of Valencia, 46010 Valencia, Spain.
- CIBER Diabetes y Enferemedades Metabolicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
| | - Maximino Redondo
- Biochemistry Department, Agencia Sanitaria Costa del Sol, University of Málaga, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), 29603 Marbella, Málaga, Spain.
| | - Maria Morales-Suarez-Varela
- Unit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, 46100 Valencia, Spain.
- CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
- Center for Advanced Research in Public Health (CSISP-FISABIO), 46010 Valencia, Spain.
| |
Collapse
|
10
|
Martínez F, Furió E, Fabiá MJ, Pérez AV, González-Albert V, Rojo-Martínez G, Martínez-Larrad MT, Mena-Martín FJ, Soriguer F, Serrano-Ríos M, Chaves FJ, Martín-Escudero JC, Redón J, García-Fuster MJ. Risk factors associated with retinal vein occlusion. Int J Clin Pract 2014; 68:871-81. [PMID: 24548738 DOI: 10.1111/ijcp.12390] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
AIMS Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after diabetic retinopathy in which arterial risk factors are much more relevant than venous factors. The objective was to evaluate the role of risk factors in the development of the first episode of RVO. SUBJECTS AND METHODS One hundred patients with RVO [mean age 56 years, 42% females and mean body mass index (BMI) 27.5 kg/m(2)] were recruited consecutively from the outpatient clinic of a tertiary hospital in Valencia (Spain). All subjects underwent clinical assessment including anthropometric and blood pressure measurements and laboratory test including homocysteine, antiphospholipid antibodies (aPLAs) and thrombophilia studies. In half of the subjects, a carotid ultrasonography was performed. Three control populations matched by age, sex and BMI from different population-based studies were used to compare the levels and prevalence of arterial risk factors. One cohort of young patients with venous thromboembolic disease was used to compare the venous risk factors. RESULTS Blood pressure levels and the prevalence of hypertension were significantly higher in the RVO population when compared with those for the general populations. There was also a large proportion of undiagnosed hypertension within the RVO group. Moreover, carotid evaluation revealed that a large proportion of patients with RVO had evidence of subclinical organ damage. In addition, homocysteine levels and prevalence of aPLAs were similar to the results obtained in our cohort of venous thromboembolic disease. CONCLUSIONS The results indicate that hypertension is the key factor in the development of RVO, and that RVO can be the first manifestation of an undiagnosed hypertension. Furthermore, the majority of these patients had evidence of atherosclerotic disease. Among the venous factors, a thrombophilia study does not seem to be useful and only the prevalence of hyperhomocysteinaemia and aPLAs is higher than in the general population.
Collapse
Affiliation(s)
- F Martínez
- Internal Medicine Department, Fundación de Investigación del Hospital Clínico de Valencia- INCLIVA, Hospital Clínico Universitario, Universidad de Valencia, Valencia, Spain; "Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología, Obesidad y Nutrición (CIBEROB)", Institute of Health Carlos III, Minister of Health, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Mansego ML, Martínez F, Martínez-Larrad MT, Zabena C, Rojo G, Morcillo S, Soriguer F, Martín-Escudero JC, Serrano-Ríos M, Redon J, Chaves FJ. Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One 2012; 7:e31853. [PMID: 22396741 PMCID: PMC3292554 DOI: 10.1371/journal.pone.0031853] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2011] [Accepted: 01/13/2012] [Indexed: 12/21/2022] Open
Abstract
Summary The main objective was to evaluate the association between SNPs and haplotypes of the FABP1-4 genes and type 2 diabetes, as well as its interaction with fat intake, in one general Spanish population. The association was replicated in a second population in which HOMA index was also evaluated. Methods 1217 unrelated individuals were selected from a population-based study [Hortega study: 605 women; mean age 54 y; 7.8% with type 2 diabetes]. The replication population included 805 subjects from Segovia, a neighboring region of Spain (446 females; mean age 52 y; 10.3% with type 2 diabetes). DM2 mellitus was defined in a similar way in both studies. Fifteen SNPs previously associated with metabolic traits or with potential influence in the gene expression within the FABP1-4 genes were genotyped with SNPlex and tested. Age, sex and BMI were used as covariates in the logistic regression model. Results One polymorphism (rs2197076) and two haplotypes of the FABP-1 showed a strong association with the risk of DM2 in the original population. This association was further confirmed in the second population as well as in the pooled sample. None of the other analyzed variants in FABP2, FABP3 and FABP4 genes were associated. There was not a formal interaction between rs2197076 and fat intake. A significant association between the rs2197076 and the haplotypes of the FABP1 and HOMA-IR was also present in the replication population. Conclusions The study supports the role of common variants of the FABP-1 gene in the development of type 2 diabetes in Caucasians.
Collapse
Affiliation(s)
- Maria Luisa Mansego
- Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas “CIBERDEM”, Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Fernando Martínez
- Fundación de Investigación del Hospital Clínico de Valencia- INCLIVA; Hypertension Clinic, Hospital Clínico Universitario, University of Valencia, Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología, Obesidad y Nutrición [CIBEROB (CIBER 03/06)], Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Maria Teresa Martínez-Larrad
- Hospital Clínico San Carlos, Department of Internal Medicine II, Plaza Cristo Rey, Madrid, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Carina Zabena
- Hospital Clínico San Carlos, Department of Internal Medicine II, Plaza Cristo Rey, Madrid, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Gemma Rojo
- Endocrinology and Nutrition Department, Carlos Haya University Hospital, Málaga, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Sonsoles Morcillo
- Endocrinology and Nutrition Department, Carlos Haya University Hospital, Málaga, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Federico Soriguer
- Endocrinology and Nutrition Department, Carlos Haya University Hospital, Málaga, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | | | - Manuel Serrano-Ríos
- Hospital Clínico San Carlos, Department of Internal Medicine II, Plaza Cristo Rey, Madrid, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| | - Josep Redon
- Fundación de Investigación del Hospital Clínico de Valencia- INCLIVA; Hypertension Clinic, Hospital Clínico Universitario, University of Valencia, Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología, Obesidad y Nutrición [CIBEROB (CIBER 03/06)], Institute of Health Carlos III, Ministry of Health, Madrid, Spain
- * E-mail:
| | - Felipe Javier Chaves
- Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain
- Centro de Investigación Biomédica en Red (CIBER) de Diabetes y Enfermedades Metabólicas Asociadas “CIBERDEM”, Institute of Health Carlos III, Ministry of Health, Madrid, Spain
| |
Collapse
|
12
|
Abellán R, Mansego ML, Martínez-Hervás S, Morcillo S, Pineda-Alonso M, Carmena R, Real JT, Redon J, Rojo-Martínez G, Martín-Escudero JC, Chaves FJ. Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis 2011; 219:900-6. [PMID: 21978921 DOI: 10.1016/j.atherosclerosis.2011.09.018] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/24/2011] [Revised: 07/05/2011] [Accepted: 09/10/2011] [Indexed: 01/13/2023]
Abstract
BACKGROUND ABCG1 mediates cellular cholesterol transport, but there is very little known about the influence of ABCG1 polymorphisms on human plasma lipoprotein cholesterol concentrations or on the interactions of these polymorphisms with diet. OBJECTIVE Our objective was to investigate whether interactions between PUFA intake and ABCG1 polymorphisms modulate associations with plasma total cholesterol (TC), LDL- and HDL-cholesterol in two Spanish populations. METHODS We grounded our investigation on two general population-based studies: the Hortega study (population A) and the Pizarra study (population B). Participants included 1178 individuals (50.0% women, age range 21-85 years) and 763 individuals (66% women, age range 23-73 years) from populations A and B, respectively, without lipid lowering drugs. Subjects were genotyped for ABCG1 variants. Biochemical measurements were taken by standard procedures. Dietary intakes were estimated with a validated questionnaire. RESULTS In population A, the A allele homozygotes of SNP rs4148102 had higher TC and LDLc concentrations in subjects on a high PUFA diet than did the carriers of the G allele (242.1 ± 38.9 vs. 198.0 ± 36.0mg/dL, p = 0.003, and 149.8 ± 37.9 vs. 111.4 ± 32.1mg/dL, p = 0.005, respectively), and significant gene-diet interactions were observed (p=0.020 and p = 0.013, respectively). In population B, similar differences in TC and LDLc concentrations were also found in association with this SNP under a high PUFA diet (253.2±24.9 vs. 197.7 ± 39.9 mg/dL, p = 0.009, and 171.8 ± 20.5 vs. 120.4 ± 34.2mg/dL, p = 0.004, respectively), but the gene-diet interactions observed were not significant (p = 0.379 and p = 0.422, respectively). In the pooled populations, differences in the TC and LDLc concentrations increased (246.8 ± 32.9 vs. 198.0 ± 37.5, p = 6 × 10(-5), and 159.0±32.6 vs. 114.3 ± 33.1, p = 3 × 10(-5), respectively), and significant gene-diet interactions were maintained (p = 0.006 and p = 0.003, respectively). CONCLUSION In two Spanish populations, the ABCG1 polymorphism rs4148102 was associated with variations in plasma lipoprotein cholesterol concentrations in subjects with high PUFA intakes. Carriers of the AA genotype consuming high PUFA diet showed higher plasma LDLc concentrations.
Collapse
Affiliation(s)
- Rosario Abellán
- Fundación Investigación Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Avda Blasco Ibáñez 17, 46010 Valencia, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
|
14
|
Morales-Suárez-Varela MM, Mansego ML, Martín-Escudero JC, Llopis-González A, Chaves FJ, López-Izquierdo R, Frutos-Llanes R, Vicedo-Cabrera AM. How ineffective hypertension control in subjects treated with angiotensin-converting enzyme inhibitors is related to polymorphisms in the renin-angiotensin-aldosterone system. Eur J Pharm Sci 2010; 39:380-6. [DOI: 10.1016/j.ejps.2010.01.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2009] [Revised: 01/11/2010] [Accepted: 01/11/2010] [Indexed: 10/19/2022]
|
15
|
Morchón-Simón D, Martín-Escudero JC. [Relationship between the BODE index and the EuroQol-5D in patients hospitalized with COPD]. Arch Bronconeumol 2009; 45:620. [PMID: 19450916 DOI: 10.1016/j.arbres.2009.03.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2009] [Accepted: 03/18/2009] [Indexed: 11/26/2022]
|
16
|
Blesa S, Vernia S, Garcia-Garcia AB, Martinez-Hervas S, Ivorra C, Gonzalez-Albert V, Ascaso JF, Martín-Escudero JC, Real JT, Carmena R, Casado M, Chaves FJ. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia. J Clin Endocrinol Metab 2008; 93:3577-83. [PMID: 18559913 DOI: 10.1210/jc.2008-0269] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
CONTEXT Autosomal dominant hypercholesterolemia (ADH) is a genetic disorder characterized by increased low-density lipoprotein (LDL)-cholesterol levels, leading to high risk of premature cardiovascular disease. More than 900 mutations in LDL receptor, six in APOB and 10 in PCSK9 have been identified as a cause of the disease in different populations. All known mutations in PCSK9 causing hypercholesterolemia produce an increase in the enzymatic activity of this protease. Up to now, there are data about the implication of PCSK9 in ADH in a low number of populations, not including a Spanish population. OBJECTIVE The objective of the study was to study the prevalence of PCSK9 mutations in ADH Spanish population. PARTICIPANTS We screened PCSK9 gene in 42 independent ADH patients in whom mutations in LDL receptor and APOB genes had been excluded. RESULTS None of the known mutations causing ADH was detected in our sample, but we found two variations in the promoter region that could cause ADH, c.-288G>A and c.-332C>A (each in one proband). The analysis of the effect of these two variations on the transcription activity of the PCSK9 promoter showed that c.-288G>A did not modify the transcription, whereas c.-332C>A variant caused a 2.5-fold increase when compared with the wild-type sequence, either with or without lovastatin. CONCLUSIONS PCSK9 is a rare cause of ADH in Spanish population and, up to what we know, none of the previously described mutations has been detected. We have identified a new mutation that could cause ADH by increasing the transcription of PCSK9.
Collapse
Affiliation(s)
- Sebastian Blesa
- Laboratorio de Estudios Genéticos, Fundación de Investigación Hospital Clínico, Universitario de Valencia, Avda. Blasco Ibáñez 17, E-46010 Valencia, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Martín-Escudero JC, Pérez-Castrillón JL, Blanco FS, Arzua-Mouronte D, Bellido Casado J, Martín JM. Relation between Bone Mass and Catecholamines in the General Population. Horm Res Paediatr 2007; 68:63-7. [PMID: 17293642 DOI: 10.1159/000099469] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/25/2006] [Accepted: 01/04/2007] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The relation between the sympathetic nervous system and bone metabolism has been known for some time, although diverse experimental studies do not show uniformity in their evaluation of the different data. The aim of this paper is to determine the relation between urinary catecholamines, as an expression of sympathetic activity, and bone mass among the general population. METHODS A study was made of 274 individuals (124 males and 150 females), who formed part of the Hortega cohort. All underwent measurement of fractionated catecholamines in urine (dopamine, noradrenaline and adrenaline) and calcaneal density, using a Pixi-Lunar (Lunar Corp., Madison, Wisc., USA). RESULTS The linear correlation study revealed a statistically significant association of dopamine with bone mass (r = 0. 229, p = 0.0001), which was not observed with the other catecholamines. The effect was shown in men (r = 0.184, p = 0.04) and women (r = 0.251, p = 0.002). When a multiple correlation analysis was performed, the effect of the dopamine (p = 0.038) persisted. CONCLUSIONS Our study shows that dopamine is an independent, positive variable for bone mass in men and women in the general population, and for the latter, it is independent of their hormonal state.
Collapse
|
18
|
Pérez-Castrillón JL, Martín-Escudero JC, del Pino-Montes J, Blanco FS, Martín FJM, Paredes MGP, Fernández FP, Arés TA. Prevalence of osteoporosis using DXA bone mineral density measurements at the calcaneus: cut-off points of diagnosis and exclusion of osteoporosis. J Clin Densitom 2005; 8:404-8. [PMID: 16311424 DOI: 10.1385/jcd:8:4:404] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2005] [Revised: 06/21/2005] [Accepted: 06/23/2005] [Indexed: 11/11/2022]
Abstract
The objective of this article is to evaluate different T-score cut-off points in the calcaneus in order to establish the prevalence of osteoporosis in the general population and to evaluate the clinical value of bone mineral density at the calcaneus as a tool to identify patients with spine or hip osteoporosis. A total of 1455 people (727 women and 728 men) from the Hortega cohort were studied. The densitometric studies were carried out in the calcaneal region using a Peripheral Instantaneous X-ray Imaging (PIXI) Lunar bone densitometer. We established three cut-off points (-1.6, -2.0, -2.5). One-hundred twenty-five patients (67 men with a mean age of 47 +/- 13 yr and 58 women with a mean age of 66 +/- 8 yr) from internal medicine outpatient clinics who were undergoing densitometry of the calcaneus, spine, and hip were subsequently studied. The prevalence of osteoporosis in women with a calcaneus T-score -1.6 was 12.4%, which is comparable to the 12.7% obtained with an axial densitometer in a Spanish population. The prevalence in men was 7.8%, with a calcaneus T-score of <-2.0. In women, the highest sensitivity (85%) was obtained with a calcaneus T-score of <-1.0 and the highest specificity with a calcaneus T-score of <-2.5. In men, the best sensitivity (61%) was obtained with a calcaneus T-score of <-1.0 and the best specificity (98%) with a calcaneus T-score of <-2.5. A calcaneus T-score <-1.6 is an adequate cut-off to establish the prevalence of osteoporosis in population studies. In women, a calcaneus T-score of >-1.0 enables the diagnosis of the disease to be excluded, whereas a calcaneus T-score of <-2.5 enables the diagnosis to be confirmed and treatment to be initiated in both men and women.
Collapse
|
19
|
Pérez-Castrillón JL, Martín-Escudero JC, Alvarez Manzanares P, Cortés Sancho R, Iglesias Zamora S, García Alonso M. Hypertension as a risk factor for hip fracture. Am J Hypertens 2005; 18:146-7. [PMID: 15691630 DOI: 10.1016/j.amjhyper.2004.08.016] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
20
|
Pérez-Castrillón JL, De Luis D, Martín-Escudero JC, Asensio T, del Amo R, Izaola O. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications 2004; 18:317-21. [PMID: 15531180 DOI: 10.1016/s1056-8727(03)00072-2] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2003] [Revised: 05/19/2003] [Accepted: 05/19/2003] [Indexed: 11/29/2022]
Abstract
People with Type 2 diabetes have bone mass alterations and may have a higher risk of hip fractures. Moreover, they have increased cardiovascular risk factors. The objective of this paper is to investigate the association among non-insulin-dependent diabetes, bone mineral density (BMD), and cardiovascular risk factors. Ninety-two patients (36 males and 56 females) were studied and cardiovascular risk factors were measured: total cholesterol, triglycerides, lipoprotein(a), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), glucose, HbA1c, and microalbuminuria. The densitometric studies were carried out in the calcaneal region using a DEXA densitometer. The diabetic women had a higher BMD than the control group (0.502 +/- 0.127 vs. 0.408 +/- 0.102, P = .027). The women showed a positive relationship between BMD and triglycerides (r =. 478, P = .0001) and a negative relationship with HDL-C (r = -.322, P = .016). The men had a BMD similar to that of the control group, and there was no relationship with the cardiovascular risk factors. When a multivariate logistic regression analysis was performed with the presence of osteoporosis as a dependent variable and each lipid level, age, sex, and BMI as independent variables, only age and BMI were found to be associated with the presence of osteopososis. The diabetic women had a higher BMD than the controls, and there was no relationship between osteoporosis and cardiovascular risk factors in diabetics.
Collapse
Affiliation(s)
- José-Luis Pérez-Castrillón
- Department of Internal Medicine, Río Hortega University Hospital, Cardenal Torquemada s/n, 47010 Valladolid, Spain.
| | | | | | | | | | | |
Collapse
|
21
|
Pérez-Castrillón JL, Justo I, Silva J, Sanz A, Martín-Escudero JC, Igea R, Escudero P, Pueyo C, Diaz C, Hernández G, Dueñas A. Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am J Hypertens 2003; 16:233-5. [PMID: 12620703 DOI: 10.1016/s0895-7061(02)03263-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
BACKGROUND The purpose of this study was to assess the relationship between bone mineral density and insertion/deletion (I/D) angiotensin converting enzyme polymorphism (ACE) in hypertensive postmenopausal women. METHODS Blood and urine samples from the study subjects were analyzed for calcium metabolism related parameters. Densitometry studies were conducted in the lumbar spine (L2 to L4). The ACE polymorphism was analyzed by polymerase chain reaction. RESULTS Women with II genotype showed a higher intact parathyroid hormone (76 +/- 33 v 55 +/- 27 pg/mL and 52 +/- 26 pg/mL, P =.034) without a decrease in calciuria, and higher bone mineral density than women with ID and homozygotus deletion genotype (1.138 +/- 0.08 v 1.051 +/- 0.16 pg/mL and 1.053 +/- 0.16 pg/mL). CONCLUSIONS The ACE polymorphism could be one of the factors causing bone mass variations.
Collapse
Affiliation(s)
- José Luis Pérez-Castrillón
- Departamento Medicina Interna, Hospital Universitario Río Hortega, Facultad de Medicina, Valladolid, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Martín-Escudero JC, Dueñas-Laíta A, Pérez-Castrillón JL, Herreros-Fernández V. Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome). Br J Psychiatry 2003; 182:267. [PMID: 12611795 DOI: 10.1192/bjp.182.3.267] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
23
|
Dueñas-Laita A, Ruiz-Mambrilla M, Gandía F, Cerdá R, Martín-Escudero JC, Pérez-Castrillón JL, Díaz G. Epidemiology of acute carbon monoxide poisoning in a Spanish region. J Toxicol Clin Toxicol 2001; 39:53-7. [PMID: 11327227 DOI: 10.1081/clt-100102880] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND In Spain, as in most of the world, the incidence of acute carbon monoxide poisoning is probably underestimated. METHODS During an eighteen-month period we studied, by means of a standardized data collection form, all the cases of acute carbon monoxide poisoning that were diagnosed in 2 university hospitals. RESULTS During the study, 154 patients were diagnosed with carbon monoxide poisoning. The mean age was 32.2+/-15.5 years. The two principal exposure sites were the kitchen (43%) and bathroom (23%). The majority of the cases related to malfunction of the water heater (30%) and of the central heating (23%) and 68% occurred in the home. Improper combustion of butane (31%), propane (13%), and natural gas (12%) were most frequent. The most prevalent clinical manifestations were headache (94%), dizziness (56%), nausea (45%), loss of consciousness (38%), and weakness (34%). Five patients died. In 14.4%, symptoms suggested delayed neurological syndrome. The largest number of cases of poisoning occurred during the months of December and January. CONCLUSIONS Compared with previous Spanish series or with the antecedent year, acute carbon monoxide poisoning has a high prevalence in our region. Two factors appear to be essential to the accurate diagnosis of acute carbon monoxide poisoning: 1) the ability of emergency room physicians to recognize the clinical symptoms of carbon monoxide poisoning and 2) access to a carbon monoxide-oximeter.
Collapse
Affiliation(s)
- A Dueñas-Laita
- Regional Unit of Clinical Toxicology, Río Hortega University Hospital, University of Valladolid, Spain.
| | | | | | | | | | | | | |
Collapse
|
24
|
Dueñas-Laita A, Castro-Villamor MA, Martín-Escudero JC, Pérez-Castrillon JL. New clinical manifestations of acute risperidone poisoning. J Toxicol Clin Toxicol 2000; 37:893-5. [PMID: 10630278 DOI: 10.1081/clt-100102531] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
25
|
Dueñas A, Felipe S, Ruiz-Mambrilla M, Martín-Escudero JC, García-Calvo C. CO poisoning caused by inhalation of CH3Cl contained in personal defense spray. Am J Emerg Med 2000; 18:120-1. [PMID: 10674554 DOI: 10.1016/s0735-6757(00)90070-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
26
|
Pérez-Castrillón JL, González-Castañeda C, Del Campo F, González JI, Martín-Escudero JC, Herreros V. Cavitary lung lesion in a patient with Sjögren's syndrome. Postgrad Med J 1999; 75:765-6. [PMID: 10567614 PMCID: PMC1741422 DOI: 10.1136/pgmj.75.890.765] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- J L Pérez-Castrillón
- Department of Internal Medicine, University Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
| | | | | | | | | | | |
Collapse
|
27
|
Pérez-Castrillon JL, Martín-Luquero M, Martín-Escudero JC, Pascual P, Casero A, Herreros V. Endocarditis caused by Enterococcus avium. Scand J Infect Dis 1998; 29:530. [PMID: 9435051 DOI: 10.3109/00365549709011873] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Enterococcus avium has rarely been reported as a pathogen in humans. We describe a case of endocarditis caused by E. avium. It responded to ampicillin and gentamicin, although a valve replacement was necessary for severe aortic insufficiency. This microorganism should be regarded as significant in endocarditis.
Collapse
Affiliation(s)
- J L Pérez-Castrillon
- Department of Internal Medicine, Hospital Rio Hortega, University of Valladolid, Spain
| | | | | | | | | | | |
Collapse
|